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Abstract Aggregation by immune complexes of receptors
specific for the Fc region of IgG results in their internalisation
and disposal by trafficking to lysosomes. We show here that
internalisation of FcQRI by IFN-Q treated U937 cells following
receptor aggregation by cross-linking antibodies requires the
activation of two distinct signalling pathways. The pathways
were functionally dissected in streptolysin-O-permeabilised cells
by capitalising on their relative dependence on active GTP
binding proteins. One pathway required the presence of GTP-QS
or active LQ subunits, the other did not. Use of inhibitors revealed
that the LQ-independent pathway required activation of PI 3-
kinases and was PKC-independent In contrast, the LQ-dependent
pathway involved activation of phospholipase C-L and PKC, but
was PI 3-kinase-independent. Both these pathways were found to
be active in intact cells and are likely to determine receptor
trafficking following internalisation. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Receptors (FcQRs) speci¢c for the constant region (Fc) of
immunoglobulin G (IgG) are expressed on the surface of
many cells of the immune system and play a pivotal role link-
ing the cellular and humoral arms of the immune response to
antigen [1]. On myeloid cells, aggregation of these receptors
triggers a number of di¡erent e¡ector functions including
internalisation of immune complexes by endocytosis and en-
gulfment of opsonised particles through the process of phago-
cytosis.
The human high a⁄nity IgG receptor, FcQRI, is an integral
type I membrane protein [2] constitutively expressed on
monocytes and macrophage cell types. The cytoplasmic tail
of FcQRI contains no obvious signalling motif, however, it
associates non-covalently with the Q-chain which enables the
recruitment of tyrosine kinases, such as syk [3], through their
src-homology domains. These tyrosine phosphorylation events
have been shown to be involved in activation of calcium tran-
sients [4] and post-internalisation vesicular tra⁄cking of
FcQRI to lysosomes [5,6]. FcQRI has also been shown to acti-
vate phosphoinositide 3-kinases (PI 3-kinases) of the IA (p85-
dependent) and IB (G-protein LQ subunit-dependent) classes
[7]. However, although PI 3-kinases have been implicated in
regulating the internalisation and post-endocytic tra⁄cking of
various tyrosine kinase linked receptors, little is known of the
signal transduction mechanisms underlying FcQRI endocyto-
sis. In this study we have used streptolysin-O-permeabilised
cells to de¢ne the signal transduction pathways mediating the
endocytosis of FcQRI following aggregation with a cross-link-
ing antibody. We report that two distinct pathways are re-
sponsible for this. One is a tyrosine kinase/PI 3-kinase-depen-
dent step which does not require the activity of PKC or
phospholipase C, and the other is a phospholipase C-L- and
PKC-dependent mechanism that proceeds to internalise FcQRI
in the absence of PI 3-kinase activity. Both of these pathways
need to be fully active in order to allow e⁄cient internalisa-
tion of immune complexes by FcQRI.
2. Materials and methods
2.1. Materials and cells
All chemicals and antibodies were purchased from Sigma, unless
otherwise stated. Tissue culture reagents were purchased from Life
Technologies Ltd. All experiments employed the human histiocytic
lymphoma cell line, U937, and these were cultured in RPMI supple-
mented with 10% foetal calf serum (FCS), 2 mM glutamine, 10 IU/ml
penicillin and 10 mg/ml streptomycin. U937 cells were stimulated with
IFN-Q (200 ng/ml) for 18 h prior to experimentation.
2.2. Internalisation of 125I-IgG by streptolysin-O-permeabilised cells
A suspension of cells was loaded with 125I-IgG in 500 Wl PBS (pH
7.4) containing 1% BSA on ice for 30 min to occupy cell surface
FcQRI, as described previously [8]. Unbound 125I-IgG was removed
by washing with 50 ml PBS at 4‡C and the cells resuspended in
glutamate bu¡er (137 mM Na-glutamate, 2 mM MgCl2, 1 mg/ml
BSA and 20 mM Na-PIPES, pH 6.8).
30 Wl of ice-cold cell permeabilisation bu¡er (glutamate bu¡er con-
taining 66 U/ml streptolysin-O (Sigma S-5265), 3 mM Mg-ATP, 1 mM
GDP and with the free calcium concentration held at 50^100 nM
by the use of a 3 mM EGTA bu¡er system) was placed into 4 ml
polystyrene tubes. Where appropriate 48 Wg/ml of cross-linking
antibody (goat anti-human (Fab-speci¢c); Sigma I-5260), 100 WM
GTP-QS, 1 WM LQ subunits (these were puri¢ed from bovine brain
according to [9]) and were a kind gift from Dr Len Stephens, Babra-
ham Institute, Babraham Hall, Cambridge CB2 4AT, UK), 0.37 mM
genistein (Calbiochem; 345834), 50 nM wortmannin, 1 WM calphostin
C (Calbiochem; 208725) and 10 WM of the phospholipase C inhibitor,
U-73122 (Calbiochem; 662035) or its inactive analogue U-73343 (Cal-
biochem; 662041) were included in the incubation. In order to main-
tain the protein in solution, the LQ preparation contains the mild
detergent, octyl-L-D-glucopyranoside (OG). The ¢nal concentration
of OG in the permeabilised cells was 0.03% and this was found not
to a¡ect the internalisation of 125I-IgG either basally or in response to
cross-linking antibody with or without GTP-QS.
30 Wl of ice-cold 125I-IgG-pre-labelled cell suspension was added to
the permeabilisation mixture (¢nal assay volume of 60 Wl). The cells
were then warmed to 37‡C for the indicated times to allow internal-
isation and then returned to 4‡C.
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Non-internalised 125I-IgG was then removed by two washes in ice-
cold PBS (pH 2.5) and the cell-associated radioactivity determined.
Data are expressed as a percentage of total initial cell-associated
counts and presented as the mean þ S.E.M. from at least three sepa-
rate experiments (as indicated in the appropriate ¢gure legends).
2.3. Internalisation of 125I-IgG by intact cells
30 Wl of RPMI containing 20 mM HEPES and 1% FCS (RPMIHF)
was placed into 4 ml polystyrene tubes with or without 48 Wg/ml
cross-linking antibody (Sigma I-5260) and 50 nM wortmannin and
1 WM calphostin C where appropriate. 30 Wl of ice-cold 125I-IgG
preloaded cells suspended in RPMIHF were added (to a ¢nal volume
of 60 Wl as for streptolysin-O-permeabilised cells. Cells were warmed
to 37‡C for the indicated times to allow internalisation and then
returned to 4‡C. Internalised 125I-IgG was then determined as for
streptolysin-O-permeabilised cells.
3. Results
3.1. Internalisation of FcQRI in intact U937 cells
IFN-Q-primed U937 cells were loaded with 125I-hIgG1 at
4‡C in order to tag the cell surface pool of FcQRI. Internal-
isation of the receptor:ligand complex was then determined
following transfer of the cells to 37‡C. Fig. 1 shows that as
previously reported [8], addition of an antibody to aggregate
FcQRI, resulted in rapid internalisation of FcQRI such that at
least 80% of the receptor became internalised within 15 min.
We have previously reported that inhibition of PI 3-kinases
with wortmannin causes a limited reduction in FcQRI internal-
isation following aggregation [10]. Consistent with this, Fig. 1
shows that treatment of the cells with 50 nM wortmannin
caused a small inhibition of receptor internalisation, particu-
larly evident at early time points. However, the bulk of FcQRI
internalisation was resistant to inhibition by wortmannin and,
thus, may be controlled by another cell signalling pathway.
The activity of PKC has been implicated in the internalisation
of a number of receptors. We therefore investigated the e¡ect
of calphostin C, an e¡ector site inhibitor of PKC, on FcQRI
internalisation. Calphostin C at 1 WM, inhibited the internal-
isation of FcQRI by approximately 50%; a more potent inhi-
bition than wortmannin, but still not complete (Fig. 1). How-
ever, a profound inhibition of FcQRI internalisation was
observed following treatment of the cells with a combination
of wortmannin and calphostin C (Fig. 1). The inhibitory ef-
fects of wortmannin and calphostin C are roughly additive,
indicating that FcQRI may be internalised by distinct PI 3-
kinase and PKC-dependent mechanisms.
3.2. In streptolysin-O-permeabilised cells FcQRI internalisation
is PI 3-kinase-dependent
In order to further dissect the cell signalling pathways in-
volved in FcQRI internalisation we employed a cell permeabi-
lisation approach. Streptolysin-O produces large lesions in the
plasma membrane, whilst internal membranes, such as endo-
somes remain intact. Fig. 2A shows that following streptoly-
sin-O permeabilisation, cross-linking of FcQRI was able to
induce receptor internalisation by approximately two-fold.
This was abolished by wortmannin (Fig. 2A), but was resis-
tant to inhibition with calphostin C (Fig. 2B). This indicates
the presence of a PI 3-kinase-dependent pathway responsible
Fig. 1. Intact U937 cells require PI 3-kinase and PKC activities for
e⁄cient internalisation of aggregated FcQRI. IFN-Q treated U937
cells were incubated in the presence of 50 nM wortmannin (a),
1 WM calphostin C (R), a combination of both reagents (O) or re-
mained untreated (b,F) for 10 min at 37‡C. Cells were then cooled
to 4‡C and labelled with 125I-IgG1. Following removal of unbound
label, the cells were warmed to 37‡C in the presence (b,R,O,a)
and absence (F) of goat anti-human cross-linking antibody. Non-
acid releasable counts were determined at the time points indicated
and expressed as a percentage of total initial cell associated counts
(values are mean þ S.E.M. n = 6).
Fig. 2. Wortmannin sensitivity of FcQRI internalisation in streptoly-
sin-O-permeabilised cells. A: Cells were incubated in the absence
(a,b) and presence (F) of 50 nM wortmannin for 10 min at 37‡C,
cooled to 4‡C and labelled with 125I-IgG1 as for Fig. 1. The cells
were then warmed to 37‡C in permeabilisation bu¡er in the absence
(b) and presence (a,F) of goat anti-human cross-linking antibody.
Internalisation was determined as for Fig. 1 (values are mean þ
S.E.M. n = 6). B: Cells were treated as for A except that 1 WM cal-
phostin C (R) was used in place of wortmannin.
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for internalisation of FcQRI which can operate in the absence
of PKC activity.
3.3. G-protein LQ-subunits are capable of stimulating FcQRI
internalisation
As both small GTPases and heterotrimeric G-proteins have
been shown to be involved in regulation of endocytosis [11],
we tested the ability of GTP-QS to modulate FcQRI internal-
isation. Fig. 3A shows that GTP-QS was able to augment
internalisation of aggregated FcQRI by approximately two-
fold. GTP-QS can act on heterotrimeric G-proteins to liberate
LQ subunits from the heterotrimer and LQ subunits have pre-
viously been shown to regulate receptor-mediated endocytosis
[12]. We investigated this possibility by determining the e¡ect
of introduction of puri¢ed brain LQ subunits into streptolysin-
O-permeabilised cells following receptor cross-linking. Fig.
3Bshows that an identical result was obtained when GTP-QS
was replaced with LQ subunits. Moreover, co-addition of the
two reagents produced no further increase in internalisation
over that achieved by GTP-QS or LQ subunits added alone.
This indicates that GTPQS achieves its e¡ects on FcQRI inter-
nalisation via the mobilisation of LQ subunits.
3.4. G-protein LQ subunit-dependent internalisation requires
activity of PKC, but not PI 3-kinase
LQ subunits are known to directly activate phospholipase C-
L which will then result in activation of PKC via the forma-
tion of diacylglycerol. The data in Fig. 1 suggest that PKC is
involved in FcQRI internalisation. We therefore tested the
ability of calphostin C to inhibit GTP-QS/LQ-induced FcQRI
internalisation. Fig. 4 shows that calphostin C abolished
both the GTP-QS (Fig. 4A) and LQ (Fig. 4B)-dependent inter-
nalisation of FcQRI. Additionally the phospholipase C inhib-
itor, U73122, had very similar e¡ects to calphostin C on GTP-
QS-dependent events, whereas its inactive isomer, U73343, was
ine¡ective in this regard (Fig. 5B).
Wortmannin, which was able to completely inhibit the LQ-
independent component of internalisation (Fig. 2A), had no
e¡ect on GTP-QS- (Fig. 4A) nor LQ- (Fig. 4B) dependent
Fig. 3. LQ-dependent FcQRI internalisation. A: IFN-Q treated U937
cells were cooled to 4‡C and labelled with 125I-IgG1. Following re-
moval of unbound label, the cells were warmed to 37‡C in permea-
bilisation bu¡er in the absence (a) and presence (R,O) of 100 WM
GTP-QS and the presence (a,O) and absence (R) of goat anti-hu-
man cross-linking antibody. Internalisation was determined as for
Fig. 1 (values are mean þ S.E.M. n = 6). B: Cells were treated as for
A, except that cells were permeabilised in the absence (a) and pres-
ence (E,P,b) of 1 WM puri¢ed brain LQ subunits and the presence
(a,E,b) and absence (P) of goat anti-human cross-linking antibody.
A series was also included to investigate the combined presence of
100 WM GTP-QS, 1 WM LQ subunits and cross-linking antibody (E).
Fig. 4. Calphostin C sensitivity of LQ-dependent FcQRI internalisa-
tion. IFN-Q treated U937 cells were incubated in the presence of 50
nM wortmannin (R), 1 WM calphostin C (F), or remained untreated
(b) for 10 min at 37‡C. Cells were then cooled to 4‡C and labelled
with 125I-IgG1. Following removal of unbound label, the cells were
warmed to 37‡C in permeabilisation bu¡er in the presence of goat
anti-human cross-linking antibody with 100 WM GTP-QS (A) or
1 WM LQ subunits (B). Internalisation was determined as for Fig. 1
and then plotted as the value obtained in the presence of GTP-QS
(A) or LQ subunits (B) with the corresponding values obtained in
the absence of these reagents subtracted (values are mean þ S.E.M.
n = 8).
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FcQRI internalisation. This indicates that FcQRI may be in-
ternalised by a phospholipase C-L and PKC-dependent path-
way that does not require the activity of PI 3-kinases.
4. Discussion
In this study we have shown that internalisation of FcQRI
by IFN-Q-treated U937 cells following receptor aggregation
requires the activation of two distinct pathways. The path-
ways were functionally dissected using streptolysin-O-permea-
bilised cells by capitalising on their relative dependence on
active GTP binding proteins. One pathway required the pres-
ence of GTP-QS or active LQ subunits, the other did not. Use
of inhibitors revealed that the LQ-independent pathway re-
quired activation of PI 3-kinases and was PKC-independent.
By contrast, the LQ-dependent pathway involved activation of
PKC and was PI 3-kinase-independent. Both these pathways
were found to be active in intact cells, with the PKC-depen-
dent pathway predominating.
The data in Fig. 1 and previous work [10] suggest that a
proportion of surface FcQRI needs the activity of PI 3-kinase
in order to be internalised. Use of streptolysin-O-permeabi-
lised cells reveals that this is likely owing to the presence of a
subpopulation of receptor that is completely dependent on PI
3-kinase activity for internalisation, rather than a partial e¡ect
of the inhibitor on a single pathway. We have shown previ-
ously that cross-linking of FcQRI results in the stimulation of
p85-dependent PI 3-kinase activity [7] and a recent study in-
dicates that this may be downstream of the recruitment of the
tyrosine kinase, Syk to FcQ receptors [13]. Previous work uti-
lising a dominant negative vp85 shows that the limited e¡ects
of wortmannin on FcQRI internalisation are likely to be via a
p85-dependent PI 3-kinase [10].
It has been suggested that PI 3-kinases can modulate endo-
cytosis via the regulation of GTPase activity or GTP exchange
rates of small GTPases involved in clathrin coated pit forma-
tion, for instance dynamin and rab5 [14]. In general, however,
reports on the sensitivity of clathrin-dependent endocytosis to
wortmannin are not consistent. It is possible, therefore, that
p85-dependent FcQRI internalisation is not via a clathrin-de-
pendent process and it seems agreed in the literature that
macropinocytic £uid-phase endocytosis is acutely sensitive to
PI 3-kinase inhibition [14]. This suggests that wortmannin-
sensitive FcQRI internalisation represents a subpopulation of
receptors amenable to internalisation by macropinocytic £uid-
phase endocytosis, a process that has been shown to be essen-
tial for e⁄cient antigen processing and presentation in macro-
phage-like cells [15].
The present study indicates that, although a proportion of
FcQRI is internalised via a PI 3-kinase-dependent mechanism,
the majority of it follows a PKC-dependent route into the cell.
The data from the streptolysin-O-permeabilised cells show
clearly that this mechanism is completely dependent on the
activity of phospholipase C-L and PKC and completely inde-
pendent of a wortmannin-sensitive PI 3-kinase. PKC has been
shown to be required for endocytosis under certain circum-
stances [16] and, as with PI 3-kinase, the mechanism for this is
unclear. However, dynamin is known to act as a PKC sub-
strate and phosphorylation by PKC is known to regulate the
GTPase activity of dynamin [17]. The sensitivity to calphostin
C, combined with the fact that internalisation proceeds at a
relatively low intracellular calcium concentration (50^100 nM
free calcium ions in the streptolysin-O permeabilisation bu¡-
er), suggest that LQ-dependent FcQRI internalisation is medi-
ated via a novel PKC. Of these, PKCs N and O are known to
be recruited to membranes following cross-linking of FcQRI in
IFN-Q-treated U937 cells [18] and recently it has been shown
that activation of FcQ receptors activates PKC-N in a PI 3-
kinase-independent fashion [13]. This make PKC-N a prime
candidate for the PKC isoform mediating FcQRI endocytosis.
Streptolysin-O-permeabilised cells will be ideal for elucidation
of the PKC responsible for receptor internalisation by allow-
ing the introduction of isoform-speci¢c inhibitors of PKCs,
such as PKC-pseudosubstrate peptides and recombinant pro-
teins corresponding to the V0 regions of novel PKCs.
In conclusion, this study shows that FcQRI may be intern-
alised in response to the activation of two independent signal-
ling pathways; one requiring PI 3-kinase and the other involv-
ing G-protein LQ-subunit activation of phospholipase C-L and
thence PKC. Clearly having two such independent internal-
isation mechanisms operating on the same receptor in the
same cell will have the potential to allow for ¢ne-tuning of
immune complex internalisation and possibly prescribing their
intracellular tra⁄cking following internalisation.
Fig. 5. Phospholipase C activity is essential for GTP-QS-dependent
FcQRI internalisation. Cells were treated with the phospholipase C
inhibitor, U73122 (O), or its inactive analogue, U73343 (b) at 10
WM for 5 min, cooled to 4‡C and labelled with 125I-IgG1. The cells
were then warmed to 37‡C in permeabilisation bu¡er containing
goat anti-human cross-linking antibody in the absence (A) and pres-
ence (B) of 100 WM GTP-QS. GTP-QS-independent (A) and -depen-
dent (B) components of internalisation were determined as for Fig.
4 (values are mean þ S.E.M. n = 4).
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